This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Masashi Sakita: Innovator in Antibody Measurement Techniques
Introduction
Masashi Sakita is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the measurement of antibody activities. His innovative work has led to the development of methods that enhance the understanding of antibody interactions.
Latest Patents
Masashi Sakita holds a patent for a method titled "Method for measuring bonding activity of antibody which mimics antibody-dependent cell mediated cytotoxic activity." This invention provides a simple and effective way to evaluate the binding activities of an antibody to both an antigen and an Fc receptor. The method involves mixing the antibody with an antigen labeled with a fluorescent donor or acceptor, followed by measuring the fluorescence level after irradiation. This technique not only estimates the ADCC activity of an antibody but also aids in controlling the quality and manufacturing of antibodies.
Career Highlights
Sakita is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative solutions in the field of antibody research. With a patent portfolio that includes 1 patent, he continues to push the boundaries of scientific understanding in his area of expertise.
Collaborations
Masashi Sakita collaborates with Takayuki Yoshimori, a fellow researcher, to further advance their work in antibody measurement techniques. Their partnership exemplifies the importance of teamwork in driving innovation in biotechnology.
Conclusion
Masashi Sakita's contributions to the field of antibody measurement are noteworthy and impactful. His innovative methods have the potential to enhance research and development in biotechnology, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
